Darvish Nissim's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Mar 14, 2022
- Accession no.
- 0001178913-22-001072
- Filed
- Mar 14, 2022
- Trade date
- Mar 16, 2021-Mar 11, 2022
- Filing delay
- 363 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 3 derivative transactions. Open-market purchases total $5.14K. It was filed 363 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Darvish NissimCIK 0001793602 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | American Depositary Shares | PPurchaseAcquired | +1,200 | $4.28 | +$5,136 | 1,200 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | American Depositary Shares | AGrant or awardAcquired | +6,820 | $0.00 | $0 | 6,820 | Direct | |
| Apr 19, 2021 | American Depositary Shares | AGrant or awardAcquired | +11,884 | $0.00 | $0 | 11,884 | Direct | |
| Mar 16, 2021 | American Depositary Shares | AGrant or awardAcquired | +10,123 | $0.00 | $0 | 10,123 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.